Latest Market Speculation News

Indiana Resources Limited has explained recent unusual trading activity by revealing ongoing assay result delays and heightened investor engagement led by its new Managing Director.

Environmental Clean Technologies Limited (ECT) has requested a voluntary suspension of its shares on the ASX as it prepares to announce a significant acquisition and capital raising.

Western Gold Resources has responded to ASX inquiries about recent unusual trading activity, disclosing partial assay results from its Gold Duke drilling program while affirming compliance with continuous disclosure rules.

Carnegie Clean Energy has addressed a sharp rise in its share price and trading volume, attributing the movement to growing interest from US investors amid its wave energy ventures.

Highfield Resources clarifies its financial position amid funding uncertainties, confirming ongoing talks with major investors and a standstill on matured convertible notes. The company maintains its commitment to the Muga Potash Project despite setbacks.

Terra Metals Limited has responded to an ASX price query following a sharp rise in its share price, confirming no undisclosed information is driving the movement and highlighting the start of Phase 3 drilling at its Dante Project.

Tasmea Limited has completed a fully underwritten A$43 million institutional placement, aiming to accelerate acquisitions, reduce debt, and enhance its chances of joining the ASX 300 Index.

PolarX Limited has voluntarily suspended its ASX-listed securities as it finalizes a capital raising, aiming to lift the suspension by 8 September with a market announcement.

333D Limited has responded to ASX queries, clarifying that its Bitcoin Treasury Management Policy approval is not price sensitive, while disclosing a $370,500 Bitcoin acquisition funded partly by R&D tax incentives.

Cannindah Resources Limited has voluntarily suspended its shares from trading as it prepares to announce a significant capital raising. The suspension is set to last until the announcement or the resumption of trading on August 22.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Weebit Nano has responded to an ASX price query following a sharp rise in its share price and trading volume, attributing the activity to a misleading article on the Motley Fool website. The company denies any undisclosed price-sensitive information and confirms full compliance with ASX disclosure rules.